Hartford Hospital is an 938-bed acute care teaching hospital located in the South End of Hartford, Connecticut. Hartford Hospital was established in 1854. The hospital campus is located on Seymour Street in Hartford and is directly adjacent to the main campus of the Connecticut Children's Medical Center.

There are 867 beds in Hartford Hospital.

During the past decade, Hartford Hospital conducted 151 clinical trials. In the 10-year time frame, 151 clinical trials started and 161 clinical trials were completed, i.e. on average, 106.6% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 61 clinical trials were completed. i.e. 127.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hartford Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 78 trials, followed by "Hartford Hospital" with 53 trials sponsored, "Gynecologic Oncology Group" with 26 trials sponsored, "SWOG Cancer Research Network" with 14 trials sponsored and "NSABP Foundation Inc" with 14 trials sponsored. Other sponsors include 227 different institutions and companies that sponsored additional 138 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 89 trials as a collaborator, "NRG Oncology" with 48 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 11 trials as a collaborator, "Hartford Hospital" with 9 trials as a collaborator and "Genentech, Inc." with 8 trials as a collaborator. Other collaborators include 304 different institutions and companies that were collaborators in the rest 197 trials.

According to Clinical.Site data, the most researched conditions in "Hartford Hospital" are "Breast Cancer" (24 trials), "Recurrent Fallopian Tube Carcinoma" (17 trials), "Recurrent Ovarian Carcinoma" (17 trials), "Recurrent Primary Peritoneal Carcinoma" (16 trials) and "Heart Failure" (14 trials). Many other conditions were trialed in "Hartford Hospital" in a lesser frequency.

Most popular intervention types in "Hartford Hospital" are "Drug" (249 trials), "Other" (145 trials), "Device" (89 trials), "Biological" (62 trials) and "Procedure" (57 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (53 trials), "Paclitaxel" (40 trials), "Placebo" (35 trials) and "Carboplatin" (28 trials). Other intervention names were less common.

The vast majority of trials in "Hartford Hospital" are 277 trials for "All" genders, 126 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Hartford Hospital". undefined are not yet recruiting, 50 are recruiting, 93 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 207 completed trials in Hartford Hospital, 1 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Hartford Hospital, 28 "Phase 1" clinical trials were conducted, 96 "Phase 2" clinical trials and 143 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 24 trials, and there were also 96 trials that are defined as “Not Applicable".

Hartford Hospital has several departments that took part in Clinical trials: "Helen and Harry Gray Cancer Center at Hartford Hospital" - 27 trials, "Hartford Healthcare Cancer Institute @ Hartford Hospital" - 17 trials, "Hartford Hospital, Urogynecology Division" - 4 trials, "Hartford Hospital - Gastroenterology" - 2 trials, "Oncology Associates, PC" - 2 trials